Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Anumana wins FDA breakthrough nod for AI algorithm that detects pulmonary hypertension

FDA Status
May 23, 2022

Anumana wins FDA breakthrough nod for AI algorithm that detects pulmonary hypertension

Share
Related Articles